| CAS: | 209410-46-8 | |
| 分子式: | C19H9Cl2F2N3OS | |
| 分子量: | 436.26 | |
| 中文名称: |
| |
| 英文名称: |
| |
| 用途: | VX-745是一种有效的,选择性p38α抑制剂,IC50为10 nM,比作用于p38β选择性高22倍,对p38γ没有抑制作用。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||
| V873351 | MACKLIN | VX-745 | 99% | 138元/1mg; | 展开 | ||||||||||||||||||||||||||||||||||||
储存:-20℃ 状态:粉末 | |||||||||||||||||||||||||||||||||||||||||
| V797489 | MACKLIN | VX-745 | 10mM in DMSO | 895元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||
| SML1638 | Sigma-Aldrich | VX-745 | ≥98% (HPLC) | 1117.23元/5 MG; 4498.97元/25 MG; | 展开 | ||||||||||||||||||||||||||||||||||||
产品说明 包装 5, 25 mg in glass bottle 生化/生理作用 VX-745 is a selective blood-brain barrier penetrant inhibitor of p38 MAPKα. VX-745 showed 20-fold selectivity for p38α over p38β and a Ki value of 220 nM. VX-745 has been shown to reduce inflammation in an arthritic (AIA) mouse model and to improve performance in aged rats. 其他说明 VX-745 has been expertly reviewed and recommended by the Chemical Probes Portal. For more information, please visit the VX-745 probe summary on the Chemical Probes Portal website. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||
| 092709 | Fluorochem | 5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido[1,6-b]pyridazin-6-one | 95% | 7304元/250mg; 18150元/1g; | 展开 | ||||||||||||||||||||||||||||||||||||
基本信息
| |||||||||||||||||||||||||||||||||||||||||